Hca Healthcare (HCA) closed at $467.73 on November 2, 2026, down 1.2% from the previous close, on volume of 1,314,406 shares (30-day average 1,194,669).
Data as of November 2, 2026.
2-Nov-2026
HCA Healthcare Announces Senior Notes Offering, Plans Redemption
TipRanks (Mon, 2-Nov 5:48 PM ET)
HCA announces public offering of senior notes
Seeking Alpha News (Mon, 2-Nov 8:39 AM ET)
HCA Announces Proposed Public Offering of Senior Notes
Business Wire (Mon, 2-Nov 8:27 AM ET)
HCA Healthcare Earnings Call Highlights Growth Amid Headwinds
TipRanks (Sat, 31-Oct 8:29 PM ET)
More Than 100 HCA Healthcare Hospitals Recognized by Healthgrades for Excellence in Specialty Care
Business Wire (Thu, 29-Oct 8:30 AM ET)
TipRanks (Thu, 29-Oct 5:40 AM ET)
HCA Healthcare Reports Third Quarter 2026 Results
Business Wire (Tue, 27-Oct 7:00 AM ET)
HCA Healthcare to Host Eighth Annual 'Crush the Crisis' National Prescription Drug Take Back Day
Business Wire (Wed, 21-Oct 8:30 AM ET)
PRNewswire (Thu, 15-Oct 10:04 AM ET)
HCA Healthcare, Inc. 3rd Quarter 2026 Earnings Conference Call
Business Wire (Wed, 30-Sep 5:03 PM ET)
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.
Hca Healthcare trades on the NYSE stock market under the symbol HCA.
As of November 2, 2026, HCA stock price declined to $467.73 with 1,314,406 million shares trading.
HCA has a beta of 0.22, meaning it tends to be less sensitive to market movements. HCA has a correlation of 0.01 to the broad based SPY ETF.
HCA has a market cap of $97.71 billion. This is considered a Large Cap stock.
Last quarter Hca Healthcare reported $20 billion in Revenue and $7.22 earnings per share. This beat revenue expectation by $517 million and exceeded earnings estimates by $.57.
In the last 3 years, HCA traded as high as $556.52 and as low as $223.73.
The top ETF exchange traded funds that HCA belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
HCA has underperformed the market in the last year with a return of +0.9%, while SPY returned +11.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in HCA shares. However, HCA has outperformed the market in the last 3 month and 2 week periods, returning +18.4% and +1.9%, while SPY returned +1.7% and -1.5%, respectively. This indicates HCA has been having a stronger performance recently.
HCA support price is $465.74 and resistance is $480.64 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HCA shares will trade within this expected range on the day.